Rita's laparoscopic resection tool:
This article was originally published in Clinica
Rita Medical Systems has received US FDA 510(k) clearance to sell a laparoscopic version of its Habib 4X resection device for coagulating tissue during cancer surgery. The radiofrequency ablation-based product, which is used to coagulate a surgical resection plane, facilitates a fast dissection with limited blood loss, claimed the Fremont, California firm. US shipments of the device are expected to take place in the second half of the fourth quarter of 2006, when Rita Medical also plans to CE-mark, and start selling, the product in Europe. A non-laparoscopic version of the device has been commercially available since the third quarter of 2005. The laparoscopic device incorporates technology licensed by Rita Medical from UK firm EMcision.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.